SS&C Technologies Holdings, Inc. SSNC

Key data

The business

SS&C sells the software and the back-office labor that hedge funds, insurers, banks and asset managers use to keep their books: fund accounting, transfer agency, trade processing, regulatory reporting. Two ways to buy it. License the software and run it yourself, or hand SS&C the fund entirely and let its people strike the daily NAV, the fund-administration business that made GlobeOp and DST names. The money scales with the client. Per the 10-Q, pricing "scales as a function of our clients' assets under management, the complexity of asset classes managed, the volume of transactions." That one sentence is both the moat and the exposure. Once a $10B fund's books are struck on SS&C's system, moving them means re-plumbing the whole operation while it runs, so clients rarely leave and retention stays high, yet the same fees breathe in and out with the markets that set those clients' AUM. Founder Bill Stone has bolted on Advent, DST, Eze and the Blue Prism automation stack to widen it.

The numbers

The quarterly line is steady and accelerating, oldest to newest.

Q4 2025 is backed out from the full year. Q2 2026 revenue rose 10.3% on the year, net income 29.9%, EPS 34.7%, and adjusted earnings have beaten the sell-side four quarters running. The half grew 9.6%, slower than the quarter, and the gap is acquired, not organic.

Revenue compounded only 5.6% a year since 2021, and reported profit is worse: GAAP EPS fell from $2.99 in 2021 to a $2.39 trough in 2023 before clawing back to $3.15, a rounding error of growth across four years. That is why the GAAP P/E of 24x looks full while the stock is a decade cheap on cash: heavy acquisition amortization sits between operating income and the bottom line. The real engine is below the earnings line.

The company throws off a roughly 9% free-cash-flow yield and now spends the majority of it retiring stock, shrinking the count a few percent a year. What this memo believes that the tape does not: the GAAP earnings line understates the cash this business keeps, and at a 12-year-trough multiple the market is pricing the amortization as if it were real erosion. The print that settles it is a full year of buybacks held near the current $1B pace against flat-to-up servicing revenue.

Management

Bill Stone founded the company, chairs it, runs it, and owns a large slug, which aligns him but concentrates the succession risk. Insiders are one-way sellers: no open-market buys in a year against $13.5M sold, the bulk a single $12.9M sale by president and vice-chairman Norman Boulanger in November 2025, plan status not disclosed. Capital allocation is the tell that counts more than any Form 4. Buybacks hit $1.04B in 2025, 59% of operating cash and above the prior four years combined in intensity, executed below today's price. It runs on borrowed money: net debt is 3.3x EBITDA and interest is covered only 3.6x, a levered rollup that works while cash flow is steady and bites the moment it is not.

How it fails or surprises you

The re-rate (right tail). At 10.8x EV/EBITDA the stock sits at the floor of its 12-year range and below the 14.6x peers fetch. A move to peers alone is about 35%, before the count keeps shrinking on a 9% cash yield. The print that reveals it: two more quarters of stable AUM with the buyback held near the 2025 pace.

Flow dependence. Fees scale with client assets, so a genuine market drawdown cuts servicing revenue and EBITDA at the same time net debt at 3.3x and coverage at 3.6x refuse to flex. The plumbing does not stop, but the meter on top of it does. First sign: a down-market quarter with organic servicing revenue flat or falling.

Bought, not earned. Reported growth was 10.3% last quarter but the half was 9.6% and GAAP EPS compounded barely 5% across four years, so the compounding may be leaning on deals more than the base. If organic growth is really mid-single digits, the multiple is not as cheap as it looks. The tell is management's organic-growth figure over the next two quarters.

Closing thoughts

This is a cash compounder wearing a full GAAP multiple, priced near a decade low on the cash it actually keeps, and levered to the markets its clients are exposed to. The fatter tail is up: at a trough multiple, a 9% cash yield spent shrinking the count re-rates the stock without heroics, provided client assets hold. The thin-but-real left tail is a sharp market drawdown landing on 3.3x leverage, where falling AUM-linked fees and fixed interest meet and the buyback has to pause. What is at risk in that world is a compressed multiple and a stalled count; what is on offer in the other is a re-rate plus steady share retirement. Call the odds tilted upward, as judgment, because the balance sheet survives the bad quarter even if the stock does not enjoy it.

The bet is still that the world's hedge funds, insurers and fund managers keep paying SS&C to run the back-office plumbing that counts their money, and keep paying more as their assets grow. It breaks if those assets fall hard enough to shrink the fees while the debt stays fixed, or if clients that were supposed never to leave start leaving. The one pair that tells you first is organic servicing-revenue growth and net-debt-to-EBITDA, watched together: as long as the first holds mid-single digits and the second drifts down, the machine is working.